Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 10:32 PM
Study NCT ID:
NCT01185158
Status:
COMPLETED
Last Update Posted:
2023-11-29
First Post:
2010-08-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma
Sponsor:
University of Chicago
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-05
Start Date Type:
None
Primary Completion Date:
2004-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11
Completion Date Type:
ACTUAL
First Submit Date:
2010-08-17
First Submit QC Date:
None
Study First Post Date:
2010-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-27
Last Update Post Date:
2023-11-29
Last Update Post Date Type:
ACTUAL